skip to primary navigationskip to content
 

Business Lecture: Billy Boyle, Co-founder, Owlstone

The remarkable story of Owlstone, the company developing early cancer detection technology that aims to save 100,000 lives and $1.5bn in health care costs, will be told next week when its co-founder, Billy Boyle, presents the next Cambridge Network Business Lecture.
When May 23, 2017
from 06:00 PM to 08:00 PM
Where Mundipharma, 196 Cambridge Science Park, CB4 0AB
Add event to calendar vCal
iCal

Using leading-edge micro- and nano- fabrication techniques, Owlstone has created a complete chemical detection system that is one hundred times smaller and one thousand times cheaper than existing technologies.

There are numerous applications - across industries from security and defence to automotive and healthcare. 

The company has won widespread commercial and academic recognition for its work and the new office on the Science Park was opened last month by Tony Blair. 

Today Owlstone Medical is applying the technology to the greatest health challenges, devising a simple breath test indicating cancer, inflammatory and infectious disease.

Owlstone span-out of the Engineering Department of the University of Cambridge in 2004.

Find more information and register here.

OPdA Tweets

Upcoming events

CEGX: The spinout that’s measuring the epigenome to improve human health

Sep 12, 2017

Pfizer Lecture Theatre, Department of Chemistry, Lensfield Road

Pitching Training Event

Sep 15, 2017

Seminar Room B, 17 Mill Lane

Upcoming events

RSS Feed Latest news

Grants available through the Returning Carers Scheme - apply by 29 September

Aug 16, 2017

The Returning Carers Scheme provides funds to support career development following a career break or a period of leave for caring responsibilities.

Opportunity to apply for up to £30,000 funding from the EPSRC: apply by 16 August

Aug 08, 2017

Postdocs are invited to apply via the OPdA for funding for activities which fall under the remit of the EPSRC and the Global Challenges Research Fund.

View all news